Therapeutic Targeting of T Cells in Systemic Sclerosis
Therapeutic Targeting of T Cells in Systemic Sclerosis
Over the next 5–10 years, research will further investigate the precise contribution of T cells to SSc pathogenesis. The use of novel animal models that faithfully recapitulate the disease will aid in investigations of the role of T cells and their products and will help evaluate the use of agents that specifically target T cells and/or their products. T-cell-targeted therapies may be useful in other autoimmune diseases, not only SSc.
Future Perspective
Over the next 5–10 years, research will further investigate the precise contribution of T cells to SSc pathogenesis. The use of novel animal models that faithfully recapitulate the disease will aid in investigations of the role of T cells and their products and will help evaluate the use of agents that specifically target T cells and/or their products. T-cell-targeted therapies may be useful in other autoimmune diseases, not only SSc.
Source...